For the quarter ending 2025-09-30, RGPX has $617,764 in assets. $5,316,564 in debts. $11,659 in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and equivalents | 11,659 | 172,430 | ||
| Prepaid expenses | 36,770 | 20,250 | ||
| Total current assets | 48,429 | 192,680 | ||
| Capitalized software development | 38,472 | - | ||
| Furniture and computer equipment, net of accumulated depreciation of 5,743and 3,326as of september 30, 2025 and march 31, 2025 | 3,628 | - | ||
| Right of use assets | 527,235 | 566,353 | ||
| Furniture and computer equipment, net of accumulated depreciation of 4,585 and 3,326 as of june 30, 2025 and march 31, 2025 | - | 4,340 | ||
| Total assets | 617,764 | 763,373 | ||
| Accounts payable | 218,748 | 171,268 | ||
| Accrued compensation | 808,276 | 862,869 | ||
| Other accrued liabilities | 154,357 | 25,453 | ||
| Current portion of notes payable to shareholder | 488,797 | - | ||
| Related party advances | - | 0 | ||
| Current portion of notes payable to related parties | 214,584 | - | ||
| Current portion of notes payable to shareholder and accrued interest | - | 486,112 | ||
| Current portion of notes payable | 2,847,737 | 2,843,132 | ||
| Current portion of notes payable to related parties and accrued interest | - | 295,664 | ||
| Current portion of lease liabilities | 191,181 | 167,673 | ||
| Total current liabilities | 4,923,680 | 4,852,171 | ||
| Lease liabilities, net of current portion | 392,884 | 458,858 | ||
| Total liabilities | 5,316,564 | 5,311,029 | ||
| Common stock 0.001par value675,000,000shares authorized281,750,910and281,070,910issuedandoutstanding at september 30, 2025 and march 31, 2025 | 281,751 | 281,176 | ||
| Additional paid-in capital | 4,639,935 | 3,977,643 | ||
| Accumulated deficit | -9,620,486 | -8,806,475 | ||
| Total stockholders deficit | -4,698,800 | -4,547,656 | ||
| Total liabilities and stockholders deficit | 617,764 | 763,373 | ||
REGENEREX PHARMA, INC. (RGPX)
REGENEREX PHARMA, INC. (RGPX)